These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 1446596

  • 1. Reduction of alpha-naphthylisothiocyanate-induced hepatotoxicity by recombinant human hepatocyte growth factor.
    Roos F, Terrell TG, Godowski PJ, Chamow SM, Schwall RH.
    Endocrinology; 1992 Dec; 131(6):2540-4. PubMed ID: 1446596
    [Abstract] [Full Text] [Related]

  • 2. Protective effect of Calculus Bovis Sativus on intrahepatic cholestasis in rats induced by α-naphthylisothiocyanate.
    Wu T, Chang MJ, Xu YJ, Li XP, Du G, Liu D.
    Am J Chin Med; 2013 Dec; 41(6):1393-405. PubMed ID: 24228608
    [Abstract] [Full Text] [Related]

  • 3. Urinary metabolic fingerprinting for alpha-naphthylisothiocyanate-induced intrahepatic cholestasis in rats using Fourier transform-ion cyclotron resonance mass spectrometry.
    Hasegawa M, Ide M, Fujita T, Takenaka S.
    Toxicol Pathol; 2008 Oct; 36(6):818-26. PubMed ID: 18776161
    [Abstract] [Full Text] [Related]

  • 4. The inhibitory effect of SA3443, a novel cyclic disulfide compound, on alpha-naphthyl isothiocyanate-induced intrahepatic cholestasis in rats.
    Tanaka M, Nakata K, Mita S.
    Clin Exp Pharmacol Physiol; 1993 Sep; 20(9):543-7. PubMed ID: 8222333
    [Abstract] [Full Text] [Related]

  • 5. Relationship between alpha-naphthylisothiocyanate-induced liver injury and elevations in hepatic non-protein sulfhydryl content.
    Dahm LJ, Bailie MB, Roth RA.
    Biochem Pharmacol; 1991 Aug 22; 42(6):1189-94. PubMed ID: 1679630
    [Abstract] [Full Text] [Related]

  • 6. Effect of compound Yindan decoction on alpha-naphthylisothiocyanate-Induced acute intrahepatic cholestasis in rats.
    Sun F, Li X, Xu C, Li P, Wu J, Sui J.
    J Tradit Chin Med; 2019 Jun 22; 39(3):315-323. PubMed ID: 32186003
    [Abstract] [Full Text] [Related]

  • 7. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo.
    Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T.
    Hepatology; 1992 Nov 22; 16(5):1227-35. PubMed ID: 1427661
    [Abstract] [Full Text] [Related]

  • 8. [Effect of emodin on P-gp expression in intrahepatic cholestatic rats].
    Zhou F, Xu H.
    Zhongguo Zhong Yao Za Zhi; 2010 Apr 22; 35(7):908-11. PubMed ID: 20575398
    [Abstract] [Full Text] [Related]

  • 9. Protection against alpha-naphthylisothiocyanate-induced liver injury by decreased hepatic non-protein sulfhydryl content.
    Dahm LJ, Roth RA.
    Biochem Pharmacol; 1991 Aug 22; 42(6):1181-8. PubMed ID: 1679629
    [Abstract] [Full Text] [Related]

  • 10. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
    Yan JY, Ai G, Zhang XJ, Xu HJ, Huang ZM.
    J Ethnopharmacol; 2015 Aug 22; 172():202-13. PubMed ID: 26133062
    [Abstract] [Full Text] [Related]

  • 11. Limited protective role of V-PYRRO/NO against cholestasis produced by alpha-naphthylisothiocyanate in mice.
    Liu J, He YY, Chignell CF, Clark J, Myers P, Saavedra JE, Waalkes MP.
    Biochem Pharmacol; 2005 Jul 01; 70(1):144-51. PubMed ID: 15913567
    [Abstract] [Full Text] [Related]

  • 12. 16,16-dimethyl-PGE2 protection against alpha-naphthylisothiocyanate-induced experimental cholangitis in the rat.
    Ruwart MJ, Rush BD, Friedle NM, Stachura J, Tarnawski A.
    Hepatology; 1984 Jul 01; 4(4):658-60. PubMed ID: 6745853
    [Abstract] [Full Text] [Related]

  • 13. Effects of andrographolide on intrahepatic cholestasis induced by alpha-naphthylisothiocyanate in rats.
    Khamphaya T, Chansela P, Piyachaturawat P, Suksamrarn A, Nathanson MH, Weerachayaphorn J.
    Eur J Pharmacol; 2016 Oct 15; 789():254-264. PubMed ID: 27475677
    [Abstract] [Full Text] [Related]

  • 14. Large dose means significant effect--dose and effect relationship of Chi-Dan-Tui-Huang decoction on alpha-naphthylisothiocyanate-induced cholestatic hepatitis in rats.
    Zhao Y, Ma X, Wang J, Wen R, Jia L, Zhu Y, Li R, Wang R, Li J, Wang L, Li Y, Xiao X.
    BMC Complement Altern Med; 2015 Apr 02; 15():104. PubMed ID: 25889085
    [Abstract] [Full Text] [Related]

  • 15. Growth factor modulation of hepatic inflammation: a novel approach to the management of total parenteral nutrition-associated liver disease.
    Thatch KA, Katz MS, Haber MM, Schwartz MZ.
    J Pediatr Surg; 2010 Jan 02; 45(1):89-94. PubMed ID: 20105586
    [Abstract] [Full Text] [Related]

  • 16. Effect of betaine supplementation on changes in hepatic metabolism of sulfur-containing amino acids and experimental cholestasis induced by alpha-naphthylisothiocyanate.
    Kim YC, Jung YS, Kim SK.
    Food Chem Toxicol; 2005 May 02; 43(5):663-70. PubMed ID: 15778005
    [Abstract] [Full Text] [Related]

  • 17. HGF induces protective effects in α-naphthylisothiocyanate-induced intrahepatic cholestasis by counteracting oxidative stress.
    Salas-Silva S, Simoni-Nieves A, Razori MV, López-Ramirez J, Barrera-Chimal J, Lazzarini R, Bello O, Souza V, Miranda-Labra RU, Gutiérrez-Ruiz MC, Gomez-Quiroz LE, Roma MG, Bucio-Ortiz L.
    Biochem Pharmacol; 2020 Apr 02; 174():113812. PubMed ID: 31954718
    [Abstract] [Full Text] [Related]

  • 18. Protective effect of Echinochrome against intrahepatic cholestasis induced by alpha-naphthylisothiocyanate in rats.
    Fahmy SR, Sayed DA, Soliman AM, Almortada NY, Aal WEA.
    Braz J Biol; 2020 Apr 02; 80(1):102-111. PubMed ID: 31017240
    [Abstract] [Full Text] [Related]

  • 19. Investigations of free anthraquinones from rhubarb against alpha-naphthylisothiocyanate-induced cholestatic liver injury in rats.
    Zhao YL, Wang JB, Zhou GD, Shan LM, Xiao XH.
    Basic Clin Pharmacol Toxicol; 2009 Jun 02; 104(6):463-9. PubMed ID: 19389047
    [Abstract] [Full Text] [Related]

  • 20. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease.
    Thatch KA, Schwartz MZ, Yoo EY, Mendelson KG, Duke DS.
    J Pediatr Surg; 2008 Dec 02; 43(12):2169-73. PubMed ID: 19040928
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.